Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > Sernovas Cell Pouch technology works well.
View:
Post by Stockwonder on Jun 28, 2021 9:36am

Sernovas Cell Pouch technology works well.

This is huge. The patient is very happy with this. a billion dollar market now opens to Sernova.
Comment by MustangSalley on Jun 28, 2021 9:50am
Yes the first patient is insulin independent .... but from the portal vein top up or from the pouch itself? The other patients are not insulin independent so far . Immunosuppresion needs to be solved for a cure for TD1 . Sva apparently has a solution , but for some reason nothing has been done with immune coating. Let's hope it does not go the way of Serotoli cells.
Comment by BioTeck on Jun 28, 2021 10:02am
Sertoli, Age-X, Conformal Coating. 3 strikes and you're out? Sernova should really just sell it's pouch (patents) to Vertex at 500 million. However, that ship has probably already sailed. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities